Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
The emergence of the novel henipavirus, Langya virus, received global attention after the virus sickened over three dozen people in China. There is heightened concern that henipaviruses, as respiratory pathogens, could spark another pandemic, most notably the deadly Nipah virus (NiV). NiV causes nea...
Main Authors: | Courtney Woolsey, Viktoriya Borisevich, Alyssa C. Fears, Krystle N. Agans, Daniel J. Deer, Abhishek N. Prasad, Rachel O’Toole, Stephanie L. Foster, Natalie S. Dobias, Joan B. Geisbert, Karla A. Fenton, Robert W. Cross, Thomas W. Geisbert |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-02-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI164946 |
Similar Items
-
Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
by: Chad E. Mire, et al.
Published: (2019-06-01) -
Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013-01-01) -
Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
by: Courtney Woolsey, et al.
Published: (2022-12-01) -
Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
by: Chad E Mire, et al.
Published: (2014-01-01) -
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
by: Thomas W. Geisbert, et al.
Published: (2021-02-01)